Initial Combination Therapy in a Newly Diagnosed Patient
Posted July 25, 2013 by Doron Schneider, MD, FACPDoron Schneider, MD and Jack Leahy, MD discuss the treatment option of initial combination therapy in a newly diagnosed T2DM patient.
Doron Schneider, MD and Jack Leahy, MD discuss the treatment option of initial combination therapy in a newly diagnosed T2DM patient.
With all the things I have to cover during my 20 minute follow-up visits with my patients with diabetes, I sometimes struggle with whether or not to interrupt as they tell me about something that, at first, seems irrelevant, at least to me.
I do, however, enjoy most of these discussions as I learn about their recent to Hawaii or some fishing trip. I do enjoy living vicariously through the lives of my patients!
Doron Schneider, MD and Jack Leahy, MD discuss the pros and cons of combination therapy for as initial treatment. (17:40)
Dr. Jack Leahy, endocrinologist and general internist, Dr. Doron Schneider, weigh different initial treatment options presented by leading endocrinologists Silvio Inzucchi, MD, Alan J. Garber, MD and Laurence Kennedy, MD. (50:19)
Dr. Jack Leahy, endocrinologist and general internist, Dr. Doron Schneider, weigh different initial treatment options presented by leading endocrinologists Silvio Inzucchi, MD, Alan J. Garber, MD and Laurence Kennedy, MD
A 38-year-old Caucasian male presents to your office reporting symptoms of fatigue, thirst, and weight loss. He has not been to a physician since his late 20s. Your physical examination shows high blood pressure (150/96 mmHg) and a BMI (body-mass index) of 36 kg/m2. There is a family history of cardiovascular disease, although the patient himself reports having no personal history of cardiac symptoms or cardiovascular events.